InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Parison Amy. Director active across 1 company, notably Editas Medicine, Inc.. Aggregated, 4 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €4k. History available since 3 June 2025. The latest transaction was disclosed on 3 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations